The guidelines are an update of clinical practice guidelines IDSA published in 2009 before the H1N1 pandemic. The resource contains new information on diagnostic testing, treatment and chemoprophylaxis with antiviral medications, along with insights on outbreak management for healthcare facilities.
Here are four things to know:
1. Instead of using rapid-influenza diagnostic tests, IDSA recommends clinicians use newer, more accurate molecular tests that offer results in 15-60 minutes.
2. Individuals at high risk of developing flu complications include obese patients, young children and women who’ve recently given birth.
3. Clinicians should immediately start antivirals for high-risk patients admitted to the hospital with suspected flu, without waiting for test results. These patients should also receive antivirals even if they’ve had symptoms for more than two days.
4. Outpatients diagnosed with the flu and at high risk for complications should also receive antiviral treatment as soon as possible.
To view the full guidelines, click here.
More articles on clinical leadership and infection control:
Chicago hospital performs record 54 heart transplants in 2018
2 killed, 1 injured in Texas ambulance crash
Top 10 infection control, patient safety stories in 2018
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
